This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment
source: pixabay.com

This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment

According to a story from PR Newswire, the biopharmaceutical company Soligenix, Inc. has announced recently that its phase 3 clinical trial has officially completed enrollment. This trial is testing the…

Continue Reading This Phase 3 Cutaneous T-Cell Lymphoma Trial Has Completed Enrollment
Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval
source: pixabay.com

Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval

According to a story from BioSpace, the US Food and Drug Administration (FDA) has recently approved the drug golodirsen (marketed as Vyondys 53) as a treatment for Duchenne muscular dystrophy…

Continue Reading Treatment for Duchenne Muscular Dystrophy with Rare Mutations Accepted Under Accelerated Approval
Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval
source: pixabay.com

Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval

According to a story from prnewswire.com, the biopharmaceutical company InMed Pharmaceuticals, Inc. has recently announced that that company's Clinical Trial Application has been approved in the Netherlands. This approval will…

Continue Reading Trial Application for Experimental Cannabinoid Epidermolysis Bullosa Treatment Gains Approval
Close Menu